pubmed-article:16249748 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C0038317 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C0376622 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C1704939 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C0072980 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C0085149 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C1413882 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C1823242 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C0444506 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:16249748 | lifeskim:mentions | umls-concept:C1514873 | lld:lifeskim |
pubmed-article:16249748 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:16249748 | pubmed:dateCreated | 2005-10-26 | lld:pubmed |
pubmed-article:16249748 | pubmed:abstractText | CYP3A5 and MDR1 polymorphisms have been shown to influence tacrolimus blood concentrations and dose requirements. The aim is to determine whether these polymorphisms also affect sirolimus trough concentrations and dose requirements after kidney transplantation. | lld:pubmed |
pubmed-article:16249748 | pubmed:language | eng | lld:pubmed |
pubmed-article:16249748 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16249748 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16249748 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16249748 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16249748 | pubmed:issn | 0041-1337 | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:HaufroidVince... | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:LisonDominiqu... | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:WallemacqPier... | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:MouradMichelM | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:MouradGeorges... | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:EddourDjamila... | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:De... | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:MalaiseJacque... | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:SquiffletJean... | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:GarrigueValér... | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:16249748 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:16249748 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16249748 | pubmed:day | 15 | lld:pubmed |
pubmed-article:16249748 | pubmed:volume | 80 | lld:pubmed |
pubmed-article:16249748 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16249748 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16249748 | pubmed:pagination | 977-84 | lld:pubmed |
pubmed-article:16249748 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:meshHeading | pubmed-meshheading:16249748... | lld:pubmed |
pubmed-article:16249748 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16249748 | pubmed:articleTitle | Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids. | lld:pubmed |
pubmed-article:16249748 | pubmed:affiliation | Kidney and Pancreas Transplantation Unit, Université Catholique de Louvain, Saint Luc University Hospital, Brussels, Belgium. Michel.Mourad@chir.ucl.ac.be | lld:pubmed |
pubmed-article:16249748 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16249748 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:16249748 | pubmed:publicationType | Multicenter Study | lld:pubmed |
entrez-gene:5243 | entrezgene:pubmed | pubmed-article:16249748 | lld:entrezgene |
entrez-gene:1577 | entrezgene:pubmed | pubmed-article:16249748 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16249748 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16249748 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16249748 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16249748 | lld:pubmed |